Recombinant Dog Claudin-2 (CLDN2) is a synthetically produced version of the canine claudin-2 protein, a key component of tight junctions in epithelial and endothelial cells. This recombinant protein is engineered for research applications to study paracellular ion transport, epithelial barrier function, and disease mechanisms in veterinary and comparative biology contexts .
| Species | Length (aa) | Molecular Weight (kDa) | Key Tissue Expression |
|---|---|---|---|
| Human | 230 | 24.5 | Intestine, Kidney |
| Mouse | 230 | 24.5 | Intestine, Liver |
| Dog | ~230* | ~24.5* | Intestine, Kidney* |
| *Inferred from homology . |
Paracellular Transport: Forms cation- and water-selective channels, enabling energy-efficient ion flux in renal proximal tubules and intestinal epithelia .
Disease Relevance: Modulates mucosal healing in colitis and influences cancer progression via pathways involving EGFR and Survivin .
Antibody Cross-Reactivity:
Pathophysiological Insights:
Colitis Models: In mice, CLDN2 overexpression reduced colitis severity by enhancing mucosal repair . Similar mechanisms are hypothesized in dogs, though direct evidence remains limited .
Cancer Research: CLDN2 upregulation correlates with poor survival in human colorectal cancer, suggesting conserved oncogenic roles in canine cancers .
Expression Systems: Recombinant dog CLDN2 is produced in E. coli, HEK293, or wheat germ systems, with tags (His, GST) for purification .
Functional Assays:
Canine Claudin-2 is a tetraspan transmembrane protein with two extracellular loops (EL1 and EL2), an intracellular N-terminus, and a cytoplasmic C-terminal tail. The protein consists of 230 amino acids with a molecular weight of approximately 24.5 kDa .
The structure includes highly conserved regions, particularly the 49GLW51 sequence in the first extracellular domain, which is critical for function . Structurally, dog and human Claudin-2 share significant homology, but with key differences in certain amino acid residues that may affect antibody binding and functional properties. Both contain perimembrane cysteines in the second (TM2) and fourth (TM4) transmembrane domains that are important for protein stability and function .
Claudin-2 forms paracellular channels that polymerize in tight junction strands, creating cation- and water-selective channels through these strands. This process is known as paracellular tight junction permeability . In canine epithelial tissues, Claudin-2 primarily:
Regulates epithelial permeability by forming size- and charge-selective paracellular pores with conductances of ~90 pS
Enables passive sodium and calcium reabsorption across proximal tubules in the kidney
Facilitates paracellular water and cation fluxes in hepatobiliary tract tissues
Contributes to intestinal barrier function and nutrient absorption
Studies with Claudin-2-deficient mice have demonstrated that the absence of this protein significantly decreases net transepithelial reabsorption of Na+, Cl-, and water, confirming its critical role in epithelial function .
Several complementary techniques are available for detection and quantification:
Western Blotting: For protein expression level assessment
Immunofluorescence/Immunocytochemistry:
Sample preparation: Fix cells with 4% paraformaldehyde for 5 minutes, permeabilize with 0.1% Triton X-100 for 10 minutes, and block with 2% BSA
Analysis: Incubate with primary anti-Claudin-2 antibodies followed by fluorescence-labeled secondary antibodies
Expected result: Junctional staining pattern at cell-cell contacts
BN-PAGE (Blue Native Polyacrylamide Gel Electrophoresis):
RT-qPCR:
Trans-tight junction patch clamp technique:
A methodological approach includes:
Vector selection and cloning:
Transfection method:
Selection of stable clones:
Validation:
Functional testing:
Several complementary electrophysiological approaches provide valuable insights into Claudin-2 channel properties:
Trans-tight junction patch clamp technique:
A novel approach that detects flux across individual Claudin-2 channels
Reveals that Claudin-2 channels display conductances of ~90 pS and are gated with sub-millisecond kinetics
Kinetic analyses indicate one open and two distinct closed states
Ussing chamber measurements:
Transepithelial electrical resistance (TER) measurements:
Ion selectivity measurements:
Mutational studies have revealed several functional domains in Claudin-2:
Researchers can employ the following methods to study these mutations:
Protein-protein interaction studies:
Functional characterization:
Trans-tight junction patch clamp to measure single-channel conductance
Ussing chamber experiments to assess ion selectivity
FRET or BRET to analyze protein-protein interactions in living cells
These approaches have revealed that Claudin-2 forms homodimers and is a component of high molecular weight complexes in tight junctions , and specific residues are critical for channel function.
Claudin-2 expression changes have been documented in several canine disease models:
Kidney disease models:
Inflammatory bowel conditions:
Altered Claudin-2 expression affects intestinal barrier function
Functional consequence: Increased paracellular permeability leading to "leaky gut"
Research approach: Ex vivo intestinal permeability studies combined with tissue expression analysis
Cancer models:
Response to toxicants and infectious stressors:
Several therapeutic strategies targeting Claudin-2 are being explored:
Antibody-drug conjugates (ADCs):
Anti-Claudin-2 antibodies conjugated with cytotoxic agents (e.g., PNU) have shown efficacy against claudin-2-expressing cancer cells
These ADCs are efficiently internalized and effective at killing Claudin-2-expressing colorectal cancer cells in vitro
In vivo studies showed that PNU-conjugated anti-Claudin-2 ADCs impaired the development of CRC liver metastases
Methodological approach: Generate and characterize anti-Claudin-2 antibodies, assess binding specificities, cross-reactivity, and efficacy in cell and animal models
Tight junction modulators:
Compounds that modulate Claudin-2 channel gating could regulate epithelial permeability
Potential applications in diseases characterized by barrier dysfunction
Research approach: High-throughput screening for compounds that affect Claudin-2 channel function, followed by electrophysiological and permeability validation
Gene therapy approaches:
Recent research has revealed important insights into the complementary roles of Claudin-2 and Claudin-12:
Functional complementarity:
Methodological approaches to study this interaction:
Animal models: Generate single and double knockout mice to assess phenotypic differences
Calcium flux measurements: Compare intestinal and renal calcium permeability between wild-type, single KO, and double KO tissues
Protein interaction studies: Co-immunoprecipitation, FRET analysis, or proximity ligation assays to determine if these claudins physically interact
Functional complementation: Express both claudins in different ratios to determine if their effects on calcium permeability are additive or synergistic
Research findings:
This research highlights the importance of studying claudin family members not in isolation but as components of a complex system regulating epithelial permeability.
The discovery that Claudin-2 channels are dynamically gated rather than static pores raises important questions about the mechanisms controlling channel opening and closing:
Current understanding of channel gating:
Advanced methodological approaches:
Trans-tight junction patch clamp: Provides direct measurement of single-channel events
Site-directed mutagenesis and chemical derivatization: To identify residues involved in gating
Temperature manipulation: Channel activity is blocked by reduced temperature
Molecular dynamics simulations: Based on the claudin crystal structure to model conformational changes during gating
High-speed imaging: Combined with fluorescent protein tagging to visualize dynamic changes in claudin organization
Research considerations:
Any model of Claudin-2 function must account for the rapid opening and closing of the channel
The longer closed state may reflect transient disassembly of the claudin-2 channel complex
Understanding gating mechanisms could lead to development of pharmacological means of modulating tight junction permeability for therapeutic purposes
Recent research has revealed that certain viruses exploit Claudin-2 during infection:
Duck circovirus (DuCV) interaction with Claudin-2:
DuCV utilizes host CLDN2 proteins to enhance adhesion and infection in target organs
The capsid protein (Cap) of DuCV interacts with the extracellular loop structural domains EL1 and EL2 of CLDN2
DuCV infection triggers the MAPK-ERK signaling pathway, leading to upregulation of SP5 and CLDN2 expression
Methodological approaches to study virus-Claudin-2 interactions:
| Approach | Application | Expected Results |
|---|---|---|
| Co-immunoprecipitation (co-IP) | Identify physical interactions between viral proteins and Claudin-2 | Precipitation of protein complexes containing both viral and claudin proteins |
| GST pull-down assays | Confirm direct binding between recombinant viral and claudin proteins | Specific binding of purified proteins indicating direct interaction |
| Immunofluorescence | Visualize colocalization of viral proteins and Claudin-2 | Overlapping signals at cell-cell junctions or other cellular compartments |
| Adhesion-blocking assays | Determine if Claudin-2 facilitates viral attachment | Reduced viral binding when Claudin-2 is blocked or depleted |
| Transcriptome analysis | Identify changes in gene expression during infection | Altered expression of Claudin-2 and related pathway components |
| Promoter analysis | Study transcriptional regulation of Claudin-2 during infection | Identification of transcription factors (e.g., SP5) regulating Claudin-2 expression |
Research implications:
Understanding viral exploitation of Claudin-2 could lead to novel antiviral strategies
Claudin-2 may serve as a receptor or co-receptor for certain viruses
Viral modulation of tight junction integrity may facilitate viral spread and pathogenesis
This research direction highlights the importance of Claudin-2 not only in normal physiology but also in host-pathogen interactions.
Significant interlaboratory variability exists in MDCK cell models, affecting reproducibility of Claudin-2 studies:
Sources of variability:
Differences in claudin expression profiles, particularly Claudin-2 levels, which impact tight junction properties
Variations in cellularity and cell volume across laboratories
Differences in cell passage number and culture conditions
Variations in transepithelial electrical resistance (TER) measurements
Standardization approaches:
Proteomic quantification: Use the total protein approach (TPA) to estimate key morphometric parameters such as monolayer cellularity and volume
Claudin expression profiling: Quantify levels of Claudin-2 and other tight junction proteins
Reference standards: Include well-characterized cell lines as controls
Detailed reporting: Document passage number, culture conditions, and measurement protocols
Recommended practices:
Establish baseline Claudin-2 expression levels in your MDCK strain
Characterize trans-epithelial resistance values for your specific cells
Validate antibodies for your specific application
Include appropriate controls for each experiment
Consider using tet-regulated expression systems for tight control of Claudin-2 levels
Researchers should be aware that the relationship between Claudin-2 expression levels and tight junction modulation affects trans-epithelial resistance, which may impact experimental outcomes and interpretation .
To ensure consistent, high-quality recombinant Claudin-2 protein for research applications:
Expression system selection:
Critical quality control parameters:
Purification considerations:
Storage conditions: